European Case Law Identifier: | ECLI:EP:BA:2004:T091801.20041006 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 06 October 2004 | ||||||||
Case number: | T 0918/01 | ||||||||
Application number: | 93904830.2 | ||||||||
IPC class: | A61K 39/395 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Treatment for inflammatory bowel disease | ||||||||
Applicant name: | BIOGEN, INC. | ||||||||
Opponent name: | Neumann Lydia Ellen Celltech Therapeutics Ltd. |
||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | Main and first auxiliary request - inventive step (no) Second auxiliary request - not admissible |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t010918eu1.html
Date retrieved: 17 May 2021